1. January 2016
CURRICULUM VITAE
NAME: Nadeem Zafar, M.D., M. Phil (UK).
Associate Professor (Pathology and Clinical Laboratory
Sciences)
Director, Pathology Residency Training Program
Medical Director, School of Cytotechnology
Associate Pathologist, VA Memphis
CONTACT INFORMATION: Department of Pathology
University of Tennessee at Memphis
930 Madison #534
Memphis- TN 38163
nzafar@uthsc.edu
(901) 448-6436 (Off)
(901) 448-6979 (Fax)
EDUCATION:
Undergraduate:
- Adamjee Science College, Karachi, Pakistan, 03/76-02/78, (Higher Secondary
Certification 03/78)
Graduate/Professional School:
- Dow Medical College, Karachi, Pakistan, 03/78-02/85 (M.B.B.S {MD} -03/85)
- University of London, England, 09/86-09/91 (M.Phil- 11/91)
Internship:
- House Officer (Medicine and Surgery), Civil Hospital, Pakistan, 03/85-02/86
Residency:
- Resident, Department of Pathology, University of Texas, Houston, 07/92-06/93
- Resident, Department of Pathology, University of Tennessee, Memphis, 07/93-06/96

2. 2
Postgraduate:
- Fellowship, Cytopathology, Baptist Memorial Hospital and UTHSC Memphis, 07/96
06/97
- Fellowship, Hematopathology, University of Iowa Hospitals and Clinics, 08/00-07/01
HONORS:
- National Merit Award- Government of Pakistan, Scholarship in Science and
Technology, 1986–1990
- Consumers’ Research Council of America- One of America’s Top Physician
Pathologist 2004-2005
- Award from Child Aid Association, Karachi Pakistan, for Spearheading the
Establishment of a Cytogenetics Laboratory at National Institute of Child Health,
Karachi-Pakistan
- Presidential Award for Social Services, Dow Graduate Association of North America-
2005, 2007
- Presidential Award For Social Services, Association of Physicians of Pakistani Descent
of North America (APPNA)- 2009
- Lifetime Humanitarian Services Award, Association of Physicians of Pakistani Descent
of North America (APPNA)- 2014
LEADERSHIP TRAINING:
- Leadership Memphis- Executive training- 2012-3
BOARD CERTIFICATION:
- American Board of Pathology- Anatomic and Clinical Pathology, 1996
- American Board of Pathology- Cytopathology, 1997
- American Board of Pathology- Clinical Hematology (Hematopathology), 2004
MEDIACL LICENSURE:
- Tennessee – 37177 (active)
- California – A76294 (active)
- Pennsylvania – MD057669L (dormant)
- Michigan – 4301073547 (dormant)
SOCIETY MEMBERSHIPS:
- United States and Canadian Academy of Pathology- current

3. 3
- American Society of Cytopathology- current
UNIVERSITY (AND COLLEGE) APPOINTMENTS:
- Associate Professor, Department of Pathology, UTHSC Memphis (07/09- current)
- Assistant Professor, Department of Pathology, UTHSC Memphis (03/03- 06/09)
- Associate Professor and Medical Director (Cytotechnology), Department of
Clinical Laboratory Sciences, School of Health Sciences, UTHSC, Memphis (July 05-
current)
- Founding Director, Hematopathology Fellowship Program, UTHSC Memphis
- Residency Program Director, Department of Pathology (2011- current)
HOSPITAL/CLINICAL APPOINTMENTS AND PRIVILEGES:
- Regional One Medical Center Memphis, (03/03- current )-Staff Pathologist
- VA Medical Center Memphis (03/09- current)-Staff Pathologist
- Locum Pathologist various hospitals, including Seton Medical Center (Daly City, CA)
and Bakersfield Memorial Hospital, Bakersfield, CA, 10/02–01/03
- Associate Pathologist, Kaiser Permanente, Hayward, California, 09/01–08/02
- Visiting Pathologist, Child Aid Association Oncology Unit, Karachi- Pakistan, 10/99-
07/00
- Consultant Pathologist, Shaukat Khanum Memorial Cancer Hospital and Research
Center, Lahore, Pakistan, 09/97-09/99
PRACTICE/PROFESSIONAL EXPERIENCE:
See Hospital/Clinical Appointments Above
OTHER ACADEMIC APPOINTMENTS AND ACTIVITIES:
- Founding member- Thyroid FNA Clinic, UTHSC Memphis (2005)
- Dissertation Committee for Ph.D.- Wendy Likes, RN, UT College of Graduate Health
Sciences- (2008-2009)- Successful dissertation for Ph.D. (April 2009)- Successful
Ph.D.
- Dissertation Committee for Ph.D- Sonam Kumari, UT School of Pharmaceutical
Sciences (2015-2019)
- UTHSC Clinical Teaching Academy (CTA) – 2006, 2007

4. 4
TEACHING EXPERINECE:
- Breast Pathology- UT Memphis- M2 Core Curriculum (2 contact hours/year) 2003-
2013
- Prevention, Community and Culture- UT Memphis- M1 Core Curriculum (3 contact
hours) 2004, 2006
- Founding Fellowship Director- Hematopathology Fellowship Program-UTHSC
Memphis
VISITING PROFESSORSHIPS AND INVITED LECTURES:
1) Competency-Based Residency Education. At Aga Khan University Hospital, Karachi,
Pakistan and Armed Forces Institute of Pathology, Rawalpindi, Pakistan- December
2006- invited lecture
2) Overview of Residency Training in the US to the Karachi Division of Pakistan
Medical Association- Jan 2008- invited lecture
3) Pathology of Gastro-esophageal Reflux Disease- (AACME Category 1 CME) at Dow
University of Health Sciences alumnus meeting, 04/05, Los Angeles, CA- invited
lecture
4) Grand Round. Department of Medicine, UTHSC Division of Endocrinology- First
Anniversary of Ultrasound-Guided Thyroid Fine-Needle Aspiration Clinic. Update from
Pathology- 08/06
EDITORIAL APPOINTMENTS:
- Manuscript Reviewer- Cytopathology (Journal)
- Manuscript Reviewer- Acta Cytologica (Journal)
- Manuscript Reviewer- Diagnostic Cytopathology (Journal)
- Manuscript Reviewer- Analytical and Quantitative Cytology and Histology (Journal)
- Manuscript Reviewer- Archives of Gynecology and Obstetrics (Journal)
- Histology and Histopathology (Journal)
COMMITTEE MEBERSHIPS AND OFFICES:
- Member- National Comprehensive Cancer Care Network (NCCN) Non-Hodgkin’s
Lymphoma Expert Panel- 2010-current
- Vice Chairman- Pathology Program Directors’ Council- 2016-2017
- Secretary- Pathology Program Directors’ Council- 2014-2016
- Member-at-Large- Pathology Program Directors’ Council- 2012-2014
- Secretary, Board of Directors, Mid-South Food Bank- 2013-2014

5. 5
- Member, Cytotechnology Program Review Committee, American Society of
Cytopathology-2010-14
- Member Faculty Senate, University of Tennessee Health Science Center Memphis, 2006-
2012
- Member, Subcommittee for Elimination of Cervical Cancer by 2040, Tennessee Cancer
Coalition, State of Tennessee- 2007-2008 (Resulted in a policy document, which is
available at http://health.state.tn.us/Downloads/CervicalCancerPreventionPlan.pdf)
- Member Tennessee Cancer Coalition, a program of Tennessee Department of Health
Comprehensive Cancer Control Program- 2007-current
- Secretary- University Pathology Group: 2007-2013
- Member, Website Committee, American Society of Cytopathology- 2006-2008
- Site Visitor-Cytotechnology Programs Review Committee (CPRC), American Society of
Cytopathology- 2007-current
VOLUNTEER APPOINTMENTS
- Member, Board of Directors, Mid-South Food Bank- 2012-current
- Member/Co-Chair Social Welfare and Disaster Relief Committee of Association of
Physicians of Pakistani-Descent of North America (APPNA) (2004-2016) - helped
coordinate charitable/disaster-relief projects in Pakistan, Iran, Indonesia and US
(Hurricane Katrina and Rita) by raising over $3.0 Million in funds since 2003 and
helping transfer medical equipment to disaster areas worth more than $6 Million
- Member APPNA SEHAT (Health) Committee- 2005-2008
- Member Executive Council, Dow Graduate Association of North America- 2005, 2006
- Member Education Commission, City of Germantown TN- 2005, 2006
- Member advisory board, Give Light Foundation (www.givelight.org)- 2005-2006
- President The Dow Graduate Association of North America Endowment Fund (501-C3)-
2009-2012 (oversaw transfer of around $800,000 to my alma mater for various healthcare
related projects)
- Vice Chairman- Greater Memphis Asian American and Pacific Islander Initiative
(GMAAPI)- a White-House sponsored Initiative- 2012-2013

6. 6
GRANT/RESEARCH SUPPORT
1. UT General Clinical Research Center grant for a pilot prospective study to investigate the
application of Cytopathology in follow-up evaluation of women with Vulvar
Intraepithelial Neoplasm (VIN)- (Co-PI)- $6500
2. School of Allied Health Sciences grant for a pilot study to investigate the application of
p16-INK4A to vulvar Cytologic samples to help determine staining correlation with high-
grade vulvar dysplasia (Co-PI)- $10,000
3. PC130870 DOD (Chauhan-PI; Zafar Co-I) 09/21/2014-08/20/2017 A Novel
Therapeutic Modality for Advanced Stage Prostate Cancer Treatment- To Investigate
Ormeloxifene Use in Prostate Cancer Therapeutics.
4. 1R01CA206069-01 NIH/NCI (PI: Chauhan; Zafar Co-I) 04/01/16 - 05/30/21
(Received 12th percentile; likely to be funded) Development of Targeted
Nanotechnology Platform for Pancreatic Cancer. To Develop a Novel Therapeutic
Modality for Pancreatic Cancer Imaging and Treatment.
5. 1R01CA204552-01 NIH/NCI (PI: Chauhan; Zafar Co-I) 04/01/16 - 05/30/21
(Received12th percentile; likely to be funded) MUC13 Mucin in Colorectal Cancer
Health Disparity.
PEER-REVIEWED JOURNAL ARTICLES
1. Zafar, N., Macartney, J.C. Cell Proliferation in human gastric mucosa and carcinoma in
organ culture. Virchows Archiv (A) Pathol Anat 418:457-61, 1991; Pubmed ID: 2035259
2. Zafar, N., Moinuddin, S. M. Needle biopsy of the mediastinum. A 15-year review of 139
cases. Cancer 76:1065-68, 1995; Pubmed ID: 8625209
3. Zafar, N., Spencer D, Berry III AD. Cytological features of embryonal adenoma of the
kidney. A report of two cases. Diagnostic Cytopathol 1:42-46, 1997; Pubmed ID: 9034736
4. Shah, Syed GM, Younis, M. N., Usmani G.N., Zafar, N. Pretherapy Gallium-67 Scanning
in Paediatric Patients with Hodgkin Disease. International Journal of Kuwait Med Sciences
13: 74-77, 2004; Pubmed ID: 14755138
5. Zafar, N. Megakaryocytes in sentinel lymph node- a potential source for diagnostic error.
Breast J 13: 297-298, 2007; Pubmed ID: 17461910

7. 7
6. Vieira FO, El Gandour O, Buadi FK, Willshires GB, Zafar N. Plasmablastic lymphoma in
a previously undiagnosed AIDS patient: a case report. Head and Neck Pathology 2008; 2:
92-96
7. Zafar N, Balazs L, Benstein BD. Synchronus high grade intraepithelial lesion and
adenocarcinoma in situ of cervix in a young woman presenting with hyperchromatic
crowded groups in the cervical cytology specimen- Report of a case- Diagnostic
Cytopathology 2008; 36: 823-826; Pubmed ID: 18831021
8. Zafar N. Enterobius (Pinworm) ova in a liquid-based gynecologic cytology specimen.
Diagnostic Cytopathology- In Print; Pubmed ID: 18973269
9. Likes WM, Benstein BD, Bloom LI, Zafar N. Vulvar Intraepithelial Neoplasm- Home
Study Course For Fall 2008. American Society of Colposcopy and Cervical Pathology
(ASCCP)-. Journal of Lower Genital Tract Diseases- 2008;12:320-324; Pubmed ID-
18820549
10. Zafar N. Histoplasmosis in fine-needle aspiration cytology of axillary lymph node in an
HIV-positive woman with clinical suspicion of lymphoma- Diagnostic Cytopathology
2009; 37 (8): 584-585; Pubmed ID: 18973264
11. Mutiple authors. Cervical Cancer Prevention Plan Report to: Governor of Tennessee and
Members of the 2008 General Assembly In fulfillment of Public Acts 2006, Chapter No.
921 Tennessee Cervical Cancer Elimination Subcommittee. Available at
http://health.state.tn.us/Downloads/CervicalCancerPreventionPlan.pdf
12. Patton AL, Duncan L, Bloom L, Phaneuf G, Zafar N. Atypical squamous cells, cannot
exclude a high-grade intraepithelial lesion and its clinical significance in postmenopausal,
pregnant, postpartum, and contraceptive-use patients. Cancer Cytopathology- 2008; 114:
481-488; Pubmed ID- 18980288
13. Baqai J, Lykes W, Qureshi MN, Benstein B, Zafar N. HPV-genotyping of biopsy proven
low grade dysplas of vulva- potential implication for HPV vaccination. Lab Invest. 2009;
89: 207A-207A
14. Scheutz III MB, Zafar N, Vasef M. Instances of Mantle Cell Lymphoma Morphologically
Mimicking Other Subtypes of B-Cell Lymphoid Proliferation. South Med J 2009; 102:
369-373; Pubmed ID- 19279536 (impact factor 0.94)

8. 8
15. Benstein B, Likes W, Bloom L, Zafar N. An Unusual Artifact in A Liquid-Based Vulvar
Cytology Specimen. Diag Cytopathol 2010; 38: 117-118; Pubmed ID- 87551039 (impact
factor 1.52)
16. Zafar N, Johns C. Pleomorphic (sarcomatoid) carcinoma of lung. Cytohistologic and
immunohistochemical features. Diagn Cytopathol 2011; 39:115–116; Pubmed ID-
20091900 (impact factor 1.52)
17. Zelenetz AD, Abramson JS, Advani RH et al. (incl. Zafar N): NCCN Clinical Practice
Guidelines in Oncology- Version 2, 2011 (NCCN GuidelinesTM) Non-Hodgkin’s
Lymphomas. J. Natl Compr Canc Netw 2011;9:484-560 ((impact factor 5.112)
18. Zelenetz AD, Wierda WG, Abramson JS, et al (incl. Zafar N.): NCCN Clinical Practice
Guidelines in Oncology (NCCN Guidelines TM) Non-Hodgkin’s Lymphomas, Version 3.
2012. J. Natl Compr Canc Netw 2012;10:1487-1498 ((impact factor 5.112)
19. Qayyum S, Meacham R, Sebelik M, Zafar N. Sialolipoma of the parotid gland: Case report
with literature review comparing major and minor salivary gland sialolipomas. J Oral
Maxillofac Pathol. 2013 Jan; 17(1): 95-97 (PMC3687197)
20. Zelenetz AD, Wierda WG, Abramson JS, et al (incl. Zafar N). NCCN Guidelines Insights
for Non-Hodgkin’s Lymphomas, Version 1.2013. J Natl Compr Canc Netw
2013;11:257–273. ((impact factor 5.112)
21. Zelenetz AD, Gordon LI, Wierda WG, et al. (incl. Zafar N) NCCN Clinical Practice
Guidelines in Oncology for Non-Hodgkin’s Lymphomas, Version 2.2014. J Natl Compr Canc
Netw 2014;12:916–946. (impact factor 5.112)
22. Gupta RK, Pillappa R, Stone I, Zafar N. Basaloid carcinoma – a rare HPV-related variant of
squamous cell carcinoma of the anorectum: a case report. Indian Journal of Pathology &
Microbiology 2014;57(2):345-347 (DOI:10.4103/0377-4929.134747 PMID:24943790)
(impact factor 0.68)
23. Qayyum S, Parikh J, Zafar N. Primary renal angiosarcoma with extensive necrosis – A
difficult needle biopsy diagnosis. Case Reports in Pathology 2014;2014:
(http://www.hindawi.com/journals/cripa/2014/416170/)

9. 9
24. Yallapu MM, Khan S, Maher DM, et al. (incl. Zafar N). Anti-cancer activity of curcumin
loaded nanoparticles in prostate cancer. Biomaterials 2014; 35(30):8635-8648 (impact
factor 8.312)
25. Khan S, Zaman M, Chauhan S, et. al. (incl. Zafar N). MicroRNA-145 targets MUC13 and
suppresses growth and invasion of pancreatic cancer. Oncotarget 2014; 5(117): 7599-
7609 (impact factor 6.627)
26. Zelenetz AD, Gordon LI, Wierda WG, et al. (incl. Zafar N) NCCN Clinical Practice
Guidelines in Oncology for Non-Hodgkin’s Lymphomas, Version 4.2014. J Natl Compr Canc
Netw 2014; 12:1282–1303 (impact factor 5.112)
27. Khan S, Chauhan N, Yallapu MM, Ebeling MC, Balakrishna S, Ellis RT, Thompson PA,
Balabathula P, Behrman SW, Zafar N, Singh MM, Halaweish FT, Jaggi M, Chauhan SC.
Nanoparticle formulation of ormeloxifene for pancreatic cancer. Biomaterials 2015;
53:731-743 (impact factor 8.312)
28. Zelenetz AD, Gordon LI, Wierda WG, et al. (incl. Zafar N) NCCN Clinical Practice
Guidelines in Oncology. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Version 1.2015. J Natl Compr Canc Netw 2015; 13:326–362 (impact factor 5.112)
29. Khan S, Chauhan N, Yallapu MM, Ebeling MC, Balakrishna S, Ellis RT, Thompson PA,
Balabathula P, Behrman SW, Zafar N, Singh MM, Halaweish FT, Jaggi M, Chauhan SC.
Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in
pancreatic cancer. Cancer Res 2015; 75: 2292-2304 (impact factor 9.284)
30. Zaman M, Chauhan N, Yallapu MM, Maher D, Kumari S, Sikander M, Khan S, Jaggi M, Zafar
N, Chauhan S. Curcumin therapeutic nanoformulation for cervical cancer treatment.
Scientific Reports 2016; 6: 20051 (doi: 10. 1038/srep20051) (impact factor 5.578)
OTHER PUBLICATIONS/PRESENTATIONS:
1. In vivo and vitro uptake of [3H]-Fucose by rat gastrointestinal mucosa. Presented at the
Pathological Society of Great Britain and Ireland, Nottingham-England, July 1990
(Abstract presented and published)

10. 10
2. Alterations in [3H]-Fucose uptake by human gastrointestinal carcinoma. Presented at the
Pathological Society of Great Britain and Ireland, Nottingham-England, July 1990 (abstract
presented and published)
3. Mediastinal needle aspiration biopsy: a review of 139 cases. United States and Canadian
Academy of Pathology, Toronto-Canada. March 1995 (abstract presented and published)
4. Phyllodes tumors of breast- a chameleon with many faces. International Oncology
Conference, Lahore Pakistan. October 1998 (Abstract presented)
5. Realmof male breast disease beyond gynecomastia- A review. Shaukat Khanum
Memorial Cancer Symposium, Lahore, Pakistan. February 1999 (Abstract presented)
6. Management of well differentiated thyroid cancer in childhood and adolescence: our
experience. Shaukat Khanum Memorial Cancer Symposium, Lahore, Pakistan. February
1999 (Abstract presented)
7. Lymphomas of the breast, morphologic and immunologic assessment. United States and
Canadian Academy of Pathology, Atlanta. March 2001 (Abstract presented and published)
8. Qureshi, M. N, Bolick, D. R., Zafar, N., Pambuccian, S. E., McGlennen, R.C. To triage or not?
A multi-institutional study examining prevalence of HPV high-risk types in LSIL cases.
Modern Pathol 18:74; 2005 (Abstract presented and published)
9. Zafar, N., Hanna, A., Layfield, L.J., Ringer, P.J., Qureshi, M.N. HPV triage of LSIL cases in
women over 30 years of age is potentially cost effective: A multi-institutional study.
Diagnostic Cytopathol 105: 373; 2005 (Abstract presented and published)
10. Zafar, N., Hanna, A., Layfield, L.J., Ringer, P.J., Qureshi, M.N. To colposcope or not! HPV
testing may help triage women over 30 years with LSIL: A multi-institutional study. ASCCP
Biennial Meeting, Las Vegas. March, 2006 (Abstract presented)
11. Zafar, N., Hanna, A., Layfield, L.J., Ringer, P.J., Qureshi, M.N. Identification of high-risk
HPV subtypes in women over 30 years of age with Cytologic diagnosis of LSIL- a multi-
institutional study with potential implications for HPV type-specific management and
impending vaccines. XXV International Congress of International Academy of Pathology,

11. 11
Montreal. September, 2006 (Abstract presented)
12. Hanna A., Layfield, L.J., Ringer, P.J., Qureshi, M.N., Zafar, N. High-risk HPV subtypes in
women over 30 years of age with cytologic diagnosis of LSIL- how common are HPV Types
16 and 18? 100th Assembly of Southern Medical Association, Burlington, North Carolina.
October, 2006 (Abstract selected and presented as one of the best 25 resident oral
submissions)
13. Zafar, N., Qureshi, M.N., Benstein, B.D. Residency trainee outcome assessment for
gynecologic cytopathology- an assessment rubric incorporating Dreyfus Model of Skill
Acquisition. Cancer Cytopathol 108: 5 (suppl), 2006 (Abstract presented and published)
14. Zafar, N. A rubric incorporating ACGME-mandated competency-based outcome
assessment and Modified Dreyfus Model of Skill Acquisition- Fine Needle Aspiration
Module. Lab Invest 86, 1 (suppl), 2006 (Abstract presented and published)
15. Bhusnurmath, S., Balazs, L., Pritchard E, Zafar, N. Megakaryocytes in sentinel lymph node
may detract from identification of metastatic breast cancer or may be misdiagnosed as
metastatic carcinoma. Modern Pathol 20, 2 (suppl); 25A: 2007 (Presented at the 96th
Annual Meeting of United States and Canadian Academy of Pathology Meeting- San
Diego CA, March 24-30)
16. Zafar, N, Qureshi, M.N., Benstein, B.D. A rubric incorporating ACGME-mandated
competency-based outcome assessment and Dreyfus Model of Skill Acquisition- Body
fluids module. Cancer Cytopathol. 111, 5(suppl), 128A:2007 (Presented at the 55th
Annual Meeting of American Society of Cytopathology- Houston TX, November 2-6)
17. Baqai J, Likes W, Qureshi MN, Bloom L, Benstein BD, Zafar N. HPV Genotyping of biopsy-
proven low grade dysplasia of vulva- potential implication for HPV vaccination. United
States and Canadian Academy of Pathology Annual Meeting- Boston, March 2009,
Publication #940.
18. Zafar N, Likes W, Qureshi MN, Bloom L, Benstein BD. Brush Cytology and HPV-
Genotyping of high grade vulvar dysplasia- a prospective study. 35th European Congress
of Cytology, Lisbon- September 2009

12. 12
19. Zbytek B, Zafar N. Unusual cytologic presentations of Stage IV lung carcinoma- two
interesting cases. 35th European Congress of Cytology, Lisbon- September 2009
20. Baldwin H, Mahmoud A, Mullins A, Zafar N. Primary Renal Carcinoid: A case report and
review of the literature. College of American Pathologists Annual Meeting- Washington
DC, October 2009
21. Likes WM, Benstein B, Bloom L, Zafar N. HPV Genotyping of Biopsy-Proven VIN in an
Under-Served Community Clinic. Abstract presented at the North American Chapter of
International Society of for the Study of Vulvovaginal Disease. Houston TX, March 2009.
22. Likes WM, Benstein BD, Zafar N, Wan J, Bloom L, Cowan P, Hathaway D. Role of Vulvar
Cytology and HPV Typing for Post-Treatment Surveillance in Women with Vulvar
Intraepithelial Neoplasia. International Society for the Study of Vulvovaginal Disease.
Edinburgh (Scotland), UK. September 2009.
23. Likes WM, Benstein, BD, Zafar N, Wan J, Bloom L, Cowan P, Hathaway D. Feasibility of
liquid-based cytology for surveillance of vulvar intraepithelial neoplasia. American
Society of Colposcopy and Cervical Pathology. 99th Annual Meeting- Washington DC.
USA, March 2010.
24. Tomeh C, Cooper L, Sebelik ME, Zafar N, Oberman B. P16ink4 antigen immunoexpression
in squamous cell carcinoma of the oropharynx in the VA population. American Head and
Neck research Workshop, Arlington VA. October 2010.
25. Jeschke J, Bloom L, Schmadeka R, White L, Zafar N. An immunohistochemical comparison
between Napsin A and TTF-1 in pulmonary adenocarcinoma cell blocks. Tennessee
Society of Histotechnology Meeting, Nashville, April 2011.
26. Qayyum S, Parikh J, Zafar N. Primary Renal Angiosarcoma with Extensive Necrosis - A
Difficult Needle Biopsy Diagnosis. Poster presentation at College of American
Pathologists 2012
27. Maecham RK, Qayyum S, Sebelik ME, Zafar N. Sialolipoma of the Parotid Gland: Case
Report with Literature Review Comparing Major and Minor Salivary Gland Sialolipomas.
Poster presentation at Triological Society 2012

13. 13
28. Pillappa R, Gupta RK, Stone I, Zafar N. Title -"Isolated Small Intestinal Histoplasmosis
Causing Intestinal Obstruction in a HIV-Positive Patient - A Rare Presentation" – Poster
presented at the 2013 American Society of Clinical Pathology
29. Nour Yadak, Megan Kempe, Ilya Stone, Nadeem Zafar. Seborrheic inclusion cyst: Report
of a rare case and review of the literature-American Society of Dermatopathology 2013.
Washington D. C.
30. Nour Yadak, Raghavendra Pillappa, Nadeem Zafar. Metastatic Adenosquamous
Carcinoma of the Esophagus: An unusual dimorphic presentation of tumor at a
metastatic site. 2014 College of American Pathologists- Poster.
31. Reza Nejati, Raghavendra Pillappa, Nadeem Zafar, Louisa Balazs. Utility of Stromal p16
Expression for Distinction of Endometrial Polyp with Atypical Hyperplasia from Atypical
Endometrial Hyperplasia and Carcinoma, A Case Report and Review of Literature. 2014
College of American Pathologists Poster.
32. Raghavendra Pillappa, Nadeem Zafar. A Case of Intrahepatic Cholangiocarcinoma with
Epidermal Growth Factor Receptor Expression: Possible Marker for Targeted
Chemotherapy. 2014 American Society of Clinical Pathology Poster.
33. Nadeem Zafar, Sheema Khan, Meena Jaggi, Stephen W. Behrman, Subhash C. Chauhan.
Suppression of Pancreatic Ductal Carcinoma Growth and Invasion By Targeting MUC13
Mucin Through MicroRNA-145- A Tumor Heterograft Study in Mice. United States and
Canadian Academy of Pathology Meeting- Boston March 2015. Lab Invest 2015; 2015
(95): 451A-452A. (impact factor 3.67) (abstract presented and published)
34. Glenn Murray and Nadeem Zafar: Heterotopic Pancreas- A Clinical Mimicker of
Gastrointestinal Stromal Tumor (GIST). 2015 American Society of Clinical Pathology
Poster. Long Beach October 2015.
35. Catherine S. Morris, Clara N. Finch Cruz, Nadeem Zafar. . Limited biopsy sampling makes
it impossible to histologically differentiate between T-cell/Histiocyte-rich B-cell
lymphoma and Nodular Lymphocytic Predominant Hodgkin lymphoma- importance of
better tissue sampling and clinical correlation- 2015 American Society of Clinical
Pathology Poster. Long Beach October 2015.

14. 14
36. Jinjun Cheng and Nadeem Zafar. Extensive benign signet ring cell changes in gastric
mucosa.- 2015 College of American Pathology Meeting Poster- Nashville October 2015.
37. Khan S, Yallapu MM, Kumari S, Ganju A, Balakrishna S, Behrman SW, Zafar N, Jaggi M,
Chauhan S. Attenuation of pancreatic cancer stemness and growth by a novel magnetic
nanoparticle formulation. Cancer Res 2015 (15 Supplement), 3676-3676 (impact factor
9.284) (abstract presented and published)
38. Khan S, Chauhan N, Yallapu MM, Ebeling MC, Balakrishna S, Ellis RT, Thompson PA,
Balabathula P, Behrman SW, Zafar N, Singh MM, Halaweish FT, Jaggi M, Chauhan SC.
Generation of a novel ormeloxifene nanoparticle formulation for pancreatic cancer
treatment. Cancer Res 2015 (15 Supplement), 4392-4392 (impact factor 9.284) (abstract
presented and published)
39. Catherine Morris, Nadeem Zafar, Shawn Kaminsky. Intestinal helminths in a very large US
patient cohort- retrospective review of over 81000 colonoscopy samples. United States
and Canadian Academy of Pathology Meeting- Seattle, March 2016 (accepted for
presentation)
40. Behrman, S et al. (incl. Zafar, N): MUC13 - An early diagnostic marker for pancreatic
ductal adenocarcinoma. Digestive Disease Week 2016- San Diego, May 2016 (Submitted)
41. Behrman, S et. al. (incl. Zafar, N): MUC13 interaction with receptor tyrosine kinase HER2
drives pancreatic ductal adenocarcinoma progression. Digestive Disease Week 2016- San
Diego, May 2016 (Submitted)
42. Kashyap VK, Khan S, Sikander M, Maher DM, Kumar S, Sinha S, Yallapu MM, Zafar N, Jaggi
M, Chauhan SC. Comorbidity factors associated with Human Papillomavirus infectivity:
Implications in cervical cancer health disparity. AACR 2016- New Orleans, April 2016
(Submitted)
43. Khan S, Sikander M, Yallapu M, Ise T, Nagata S, Behrman S, Zafar N, Wan JY, Ghimire HM,
Sahay P, Pradhan P, Jaggi M, Chauhan SC. MUC13 interaction with receptor tyrosine
kinase HER2 drives pancreatic ductal adenocarcinoma progression. AACR 2016- New
Orleans, April 2016 (Submitted)

15. 15
PANEL DISCUSSION:
Michael Prystowsky, Tiffany Hebert, Nadeem Zafar: Panel Discussion Group: Onboarding:
Facilitating transition from medical school to Pathology residency. Association of Pathology
Chairs Summer Meeting- July 2015, San Diego CA.
Nadeem Zafar, Tiffany Hebert, Kristy White, Michael Prystowsky: Panel Discussion Group:
Onboarding: Facilitating transition from medical school to Pathology residency. Best practice
recommendations. Association of Pathology Chairs Summer Meeting- July 2016, San Diego CA.
PLATFORM PRESENTATION:
Nadeem Zafar. Onboarding New Pathology Residents. Findings from the National Survey of
Residency Program Directors Commissioned by the Pipeline Subcommittee of Association of
Pathology Chairs. Platform presentation at the Program Directors Section of Association of
Pathology Chairs Summer Meeting- July 2015, San Diego CA.